TWO-MODULE DEVICE OF ELECTROMIGRATION Russian patent published in 2015 - IPC A61N1/30 A61J1/05 A61M37/00 

FIELD: medicine.

SUBSTANCE: invention relates to medical equipment, namely to devices of transdermal delivery of active agents by electromigration. Corrosion-resistant device for medication delivery contains electric module and reservoir module, made with possibility of their connection before application to form single activated device for medication delivery, with device resisting corrosion due to electric isolation of circuit in electric module from electricity source. Electric module contains circuit, electric outlet for connection to inlet connector on reservoir module when electric module is connected with reservoir module and at least two terminals of power supply insertion between circuit and battery. Reservoir module contains electric inlet for electric connection of circuit in electric module to at least pair of active electrodes in reservoir module when electric module is connected with reservoir module and at least two drives of battery terminals. Second version of device implementation is additionally includes counter of switches-on, which contains logical flag and is made with possibility of increasing when circuit is switched on, with circuit disconnecting device or not switching it on, if number of counts in mentioned counter of switches-on is higher than specified value Third version of device implementation includes one or several terminals of power supply switching on between circuit and battery, first sealing, which closes one or several terminals of power switching on before modules are connected, with first sealing being made with possibility to preserve hermetic sealing, when terminal of power switching on is closed by drive, and is waterproof and/or non-penetrable for particles, and second sealing, which seals electric outlet before, during and after connection of electric and reservoir module.

EFFECT: application of invention makes it possible to extend arsenal of technical means for transdermal delivery of active agents.

29 cl, 11 dwg